Merck KGaA 0O14.IL Stock
Merck KGaA Price Chart
Merck KGaA 0O14.IL Financial and Trading Overview
Merck KGaA stock price | 0.0000 EUR |
Previous Close | 163.95 EUR |
Open | 163.95 EUR |
Bid | 164.2 EUR x 0 |
Ask | 167.65 EUR x 0 |
Day's Range | 163.9 - 166.25 EUR |
52 Week Range | 153.1 - 202.3 EUR |
Volume | 2.26K EUR |
Avg. Volume | 187.17K EUR |
Market Cap | 72.28B EUR |
Beta (5Y Monthly) | 0.623371 |
PE Ratio (TTM) | 22.34543 |
EPS (TTM) | 7.08 EUR |
Forward Dividend & Yield | 2.2 (1.29%) |
Ex-Dividend Date | May 2, 2023 |
1y Target Est | N/A |
0O14.IL Valuation Measures
Enterprise Value | 82.16B EUR |
Trailing P/E | 22.34543 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.2374187 |
Price/Book (mrq) | 2.7654867 |
Enterprise Value/Revenue | 3.68 |
Enterprise Value/EBITDA | 12.749 |
Trading Information
Merck KGaA Stock Price History
Beta (5Y Monthly) | 0.623371 |
52-Week Change | 3.20% |
S&P500 52-Week Change | 20.43% |
52 Week High | 202.3 EUR |
52 Week Low | 153.1 EUR |
50-Day Moving Average | 165.27 EUR |
200-Day Moving Average | 173.52 EUR |
0O14.IL Share Statistics
Avg. Volume (3 month) | 187.17K EUR |
Avg. Daily Volume (10-Days) | 129.84K EUR |
Shares Outstanding | 129.24M |
Float | 129.24M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 58.63% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.2 |
Trailing Annual Dividend Yield | 1.34% |
5 Year Average Dividend Yield | 110.00% |
Payout Ratio | 0.248 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 14.52% |
Operating Margin (ttm) | 21.82% |
Gross Margin | 62.01% |
EBITDA Margin | 28.86% |
Management Effectiveness
Return on Assets (ttm) | 6.42% |
Return on Equity (ttm) | 13.23% |
Income Statement
Revenue (ttm) | 22.33B EUR |
Revenue Per Share (ttm) | 51.37 EUR |
Quarterly Revenue Growth (yoy) | 1.79% |
Gross Profit (ttm) | 13.74B EUR |
EBITDA | 6.44B EUR |
Net Income Avi to Common (ttm) | 3.24B EUR |
Diluted EPS (ttm) | 7.44 |
Quarterly Earnings Growth (yoy) | -9.50% |
Balance Sheet
Total Cash (mrq) | 1.72B EUR |
Total Cash Per Share (mrq) | 3.96 EUR |
Total Debt (mrq) | 10.64B EUR |
Total Debt/Equity (mrq) | 40.58 EUR |
Current Ratio (mrq) | 1.355 |
Book Value Per Share (mrq) | 60.116 |
Cash Flow Statement
Operating Cash Flow (ttm) | 4.27B EUR |
Levered Free Cash Flow (ttm) | 1.42B EUR |
Profile of Merck KGaA
Country | United Kingdom |
State | N/A |
City | Darmstadt |
Address | Frankfurter Strasse 250 |
ZIP | 64293 |
Phone | 49 6151 72 0 |
Website | https://www.merckgroup.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 64011 |
Merck KGaA operates as a science and technology company in Germany. The company's Life Science segment offers a range of products, including reagents, consumable, devices, instruments, software, and services for scientific discovery, as well as provides lab water instruments, consumables and services, microbiology and biomonitoring, products, test assays, analytical reagents, and flow cytometry kits and instruments for pharma and biotech, industrial and testing, academics and government, and diagnostic sectors. Its Healthcare segment designs and develops medicines and intelligent devices for treatment of various therapeutics, such as oncology, neurology and immunology, endocrinology, and general medicines. The company's Electronic segment provides semiconductor solutions, such as semiconductor materials, delivery systems and services, and intermolecular services for semiconductor and polymer removal chemistries applications; and display solutions comprising liquid crystals, OLED and quantum materials, reactive mesogens, photoresist materials, smart antenna, and dynamic liquid crystal glazing products, as well as offers liviFlex, a flexible platform, which offers a range of display materials. This segment also provides surface solution, such as cosmetics, effect pigments, and functional solutions; architecture solutions, including switchable windows; and automotive solutions. In addition, it has strategic alliances with Pfizer Inc. and GlaxoSmihKline plc to develop and commercialize active ingredients in immune-oncology; in-licensing agreement with Debiopharm International SA for developing drug candidates for the treatment of head and neck cancer; and out-licensing agreement with MoonLake Immunotherapeutics AG for developing a drug candidate for the treatment of inflammatory diseases. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA is a subsidiary of E. Merck Kommanditgesellschaft.
Q&A For Merck KGaA Stock
What is a current 0O14.IL stock price?
Merck KGaA 0O14.IL stock price today per share is 0.0000 EUR.
How to purchase Merck KGaA stock?
You can buy 0O14.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Merck KGaA?
The stock symbol or ticker of Merck KGaA is 0O14.IL.
Which industry does the Merck KGaA company belong to?
The Merck KGaA industry is Drug Manufacturers-Specialty & Generic.
How many shares does Merck KGaA have in circulation?
The max supply of Merck KGaA shares is 0.
What is Merck KGaA Price to Earnings Ratio (PE Ratio)?
Merck KGaA PE Ratio is 21.69925300 now.
What was Merck KGaA earnings per share over the trailing 12 months (TTM)?
Merck KGaA EPS is 7.08 EUR over the trailing 12 months.
Which sector does the Merck KGaA company belong to?
The Merck KGaA sector is Healthcare.